|
NCSTN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.088800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.656600E-01 |
| Normal-vs-Stage2 |
2.362000E-01 |
| Normal-vs-Stage3 |
6.067400E-01 |
| Normal-vs-Stage4 |
9.080800E-01 |
| Stage1-vs-Stage2 |
3.078600E-01 |
| Stage1-vs-Stage3 |
8.674000E-01 |
| Stage1-vs-Stage4 |
8.169800E-01 |
| Stage2-vs-Stage3 |
4.156000E-01 |
| Stage2-vs-Stage4 |
2.912400E-01 |
| Stage3-vs-Stage4 |
7.326400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.674600E-01 |
| Normal-vs-AfricanAmerican |
4.860600E-01 |
| Normal-vs-Asian |
4.714600E-01 |
| Caucasian-vs-AfricanAmerican |
6.534800E-01 |
| Caucasian-vs-Asian |
5.096400E-01 |
| AfricanAmerican-vs-Asian |
4.599600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.242200E-01 |
| Normal-vs-Female |
7.968800E-01 |
| Male-vs-Female |
5.486800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.969400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.021000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.567000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.073800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.109000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.321000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.224800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.285400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.077600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.820200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.584100E-03 |
| Normal-vs-Grade 2 |
8.042600E-01 |
| Normal-vs-Grade 3 |
1.775410E-01 |
| Normal-vs-Grade 4 |
9.396200E-01 |
| Grade 1-vs-Grade 2 |
2.225700E-02 |
| Grade 1-vs-Grade 3 |
3.824300E-03 |
| Grade 1-vs-Grade 4 |
2.166000E-02 |
| Grade 2-vs-Grade 3 |
2.279800E-01 |
| Grade 2-vs-Grade 4 |
9.039400E-01 |
| Grade 3-vs-Grade 4 |
3.006400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.349400E-01 |
| Normal-vs-ccB subtype |
8.133400E-01 |
| ccA subtype-vs-ccB subtype |
8.531400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.418400E-01 |
| Normal-vs-N1 |
1.353580E-01 |
| N0-vs-N1 |
2.994100E-02 |
|
|
